{
    "title": "Root Extract of Pelargonium sidoides Is a Potent HIV-1 Attachment Inhibitor",
    "inventor_name": null,
    "publication_year": 2014,
    "device_name": "Pelargonium sidoides root extract (PS extract, EPs 7630)",
    "goal": "Inhibit HIV-1 attachment and entry into human cells to prevent viral replication and progression to AIDS",
    "problem_addressed": "HIV-1 infection leading to AIDS",
    "concept_summary": "The root extract of the medicinal plant Pelargonium sidoides (PS) contains polyphenolic compounds that directly block the attachment of HIV-1 particles to target cells, thereby preventing infection and replication. The extract has low cytotoxicity and is already licensed in Germany as the herbal medicine EPs 7630 for respiratory infections.",
    "detailed_description": null,
    "category": "Medical & Dental Technologies",
    "principles": [
        "Polyphenol-mediated inhibition of viral attachment",
        "Phytochemical antiviral activity"
    ],
    "scientific_domains": [
        "Virology",
        "Pharmacology",
        "Botany",
        "Immunology"
    ],
    "mechanisms_of_action": [
        "Blocks HIV-1 attachment to host cell receptors",
        "Interferes with viral infectivity",
        "Reduces viral entry and subsequent replication"
    ],
    "materials": [
        "Pelargonium sidoides root extract",
        "Polyphenolic compounds (e.g., gallic acid derivatives)",
        "Aqueous ethanolic extract"
    ],
    "energy_sources": [],
    "inputs": [
        "HIV-1 virus particles",
        "Human peripheral blood mononuclear cells (PBMCs)",
        "Macrophages",
        "Cell culture medium"
    ],
    "outputs": [
        "Reduced infection of target cells",
        "Inhibition of HIV-1 replication",
        "Low cytotoxicity to host cells"
    ],
    "claimed_performance": "Potent anti-HIV-1 activity in vitro; blocks viral attachment with low cytotoxicity; comparable to novel mode-of-action distinct from existing antiretroviral drugs",
    "experimental_evidence": "Multiple cell-culture experiments demonstrated protection of PBMCs and macrophages from infection with various X4 and R5 tropic HIV-1 strains, including clinical isolates; published in PLOS ONE (doi:10.1371/journal.pone.0087487)",
    "replication_status": "No independent replication reported in the article",
    "keywords": [
        "Pelargonium sidoides",
        "HIV-1",
        "Attachment inhibitor",
        "Polyphenols",
        "Phytomedicine",
        "EPs 7630",
        "Antiviral"
    ],
    "related_technologies": [
        "Other herbal antiviral extracts",
        "Plant-based antiviral supplements"
    ],
    "controversy_level": "low",
    "confidence_score": 0.85,
    "practicability_score": 0.7,
    "fringe_score": 0.2,
    "evidence_strength": 0.6,
    "risk_score": 0.2,
    "trl_estimate": 3,
    "source_urls": [
        "http://www.plosone.org/article/info:doi/10.1371/journal.pone.0087487",
        "http://www.medicaldaily.com/hiv-treatment-geranium-extracts-natural-way-fight-infection-inhibit-replication-268301",
        "http://en.wikipedia.org/wiki/Pelargonium_sidoides"
    ],
    "organizations": [
        "German Research Center for Environmental Health, Munich",
        "University of Munich"
    ],
    "applications": [
        "Adjunct therapy for HIV-1 infection",
        "Supplement to existing antiretroviral regimens"
    ],
    "limitations": [
        "Evidence limited to in-vitro cell-culture studies",
        "No clinical trial data for HIV-1 efficacy",
        "Potential variability in extract composition and potency"
    ],
    "open_questions": [
        "Does the extract demonstrate efficacy in human HIV-1 patients?",
        "What is the optimal dosing regimen for antiviral effect?",
        "Which specific polyphenolic constituents are responsible for the activity?"
    ],
    "red_flags": [
        "Claims of being the first plant-based HIV therapy without clinical validation",
        "Potential overstatement of efficacy based solely on in-vitro data"
    ],
    "evidence_quotes": [
        "\"We provide evidence from multiple cell culture experiments that PS extract displays potent anti-HIV-1 activity.\"",
        "\"The extract interferes directly with viral infectivity and blocks the attachment of HIV-1 particles to target cells.\"",
        "\"Analysis of the chemical footprint ... indicates that HIV-1 inhibition is mediated by multiple polyphenolic compounds with low cytotoxicity.\"",
        "\"PS extracts are attractive candidates for increasing anti-HIV-1 therapy options in resource-limited settings, since they are easy to produce and do not require refrigeration.\"",
        "\"The results of our study and the excellent safety profile ... encourage testing in HIV-1 infected individuals as next step.\""
    ]
}